Delivery Order SPE2DB22D1106-SPE2DB24FFHJ2

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lacosamide 10 mg/ml solution. The order, valued at $2,209.92, is part of a broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,370.40 for the supply of Lacosamide 10 mg/ml solution. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 14, 2024. The contract is a firm-fixed-price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,996.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. It has an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $4,542.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lacosamide 10 mg/ml solution in 200 ml quantities, a pharmaceutical product used for medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,145.31, is for the delivery of 4,568,113,199 units of the prescription medication Lacosamide 150 mg Tablet 60s. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
The Defense Logistics Agency Troop Support Medical awarded a $176,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 31, 2023 through August 1, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held...
The Defense Logistics Agency Troop Support Medical awarded a $207,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,190.52 Firm Fixed Price delivery order is for the pharmaceutical product Lacosamide 200 mg Tablet 60s. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA valued at $999,999,999, running through November 2026. This IDC...
The Defense Logistics Agency awarded a $138,120 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mL bottles of the pharmaceutical Lacosamide 10 mg/ml solution. The prime contractor will deliver the requested pharmaceutical product to a location in Conshohocken, Pennsylvania by July 7, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen Drug Corporation will perform as the prime contractor for this delivery order placed against an...
The Defense Logistics Agency Troop Support Medical awarded a $229,200 delivery order to Amerisourcebergen Drug Corporation for 200 milliliters of the pharmaceutical product lacosamide 10 mg/ml solution. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The firm fixed price order has a period of performance spanning August 8, 2023 through August 9, 2023. No major subcontractors or set aside designations were indicated. This delivery order was...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHJ2
    Delivery Order

This is a $3,143.51 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lacosamide 10 mg/ml solution, a prescription medication, to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities. The contract does not utilize a set-aside designation and has an ultimate completion date of August 20, 2024.

Generated 11/18/24, 9:44 AM